TradeTrade
Jump to any asset 849 assets, updated daily

As of October 10, 2026, Morgan Stanley (MS) trades at $190.02. CleaRank Financial AI rates it Hold with a fair value of $226.50, 19.2% above the current price. Wall Street's consensus target is $226.50 across 26 analysts. RSI at 21 is in oversold territory, and the price is below its 50-day average of $207.33.

Morgan Stanley (MS)

Morgan Stanley NYSE

$190.02 2.580 (1.38%)
At close: Oct 9, 4:00 PM EDT
AI Analyst Consensus
Hold
59 / 100
Morgan Stanley (MS) is currently trading at $190.02, below its 50-day and 200-day moving averages ($207.33 and $194.21), indicating a bearish short-term trend. The stock's RSI is at 20.75, signaling oversold conditions, but this is juxtaposed with heavy insider selling totaling $98.7 million against only $5.6 thousand in purchases, suggesting a lack of internal confidence. Despite these technical and insider headwinds, the company exhibits strong fundamental performance with a reported revenue growth of 28% and a net profit margin of 25.90%, exceeding sector averages in revenue growth (11.7%) and profit margin (13.8%). Wall Street analysts maintain a 'Hold' consensus with a median price target of $226.50, implying a 19.2% upside from the current price. The firm's revenue is projected to grow 17.00% year-over-year for the current year, reaching $82.3 billion. However, the significant insider selling pressure and the stock's current technical weakness present considerable risks that investors must weigh against the company's fundamental strengths and positive analyst outlook.

MS Price Analysis

Market Metrics

Open
$187.76
Day Range
$187.05 to $190.44
Prev Close
$187.44
Volume
4.72M
52-Week Range
$151.84 to $232.25
Market Cap
$298.44B

Peer Benchmarking

Valuation vs Sector (Financial Services)

Performance vs IAI

Sector Position Analysis
Valuation is broadly in line with sector peers (-7% difference), suggesting fair market pricing relative to industry standards.

MS Financial Performance

Revenue vs. Earnings

Annual

Quarterly

Earnings Reality Check

Analysis: In the last 5 quarters, MS beat estimates 4 times. However, the stock fell 4 times the next day. This suggests positive news is often "priced in" or investors are selling the news.

MS Analysis

Company's Health 4/5
12-Month Analyst Target +19.20% Upside
Median of 26 analysts (12-month)
$226.50
AI Technical Analysis Hold
Morgan Stanley (MS) is currently trading below its 50-day and 200-day moving averages ($207.33 and $194.21), signaling a bearish trend. The Relative Strength Index (RSI) is at 20.75, indicating the stock is oversold and may be due for a bounce, though this is not a guarantee of a reversal. The MACD indicator is at -5.79, further suggesting bearish momentum. Key support levels are being tested, with the current price of $190.02 sitting just below the 200-day SMA ($194.21). Volume has been below average recently, with 4.72 million shares traded compared to a 5.66 million average, suggesting a lack of conviction from the broader market. The chart structure indicates potential for further downside if the 200-day SMA fails to hold as support, especially given the heavy insider selling.
ProTips
  • Monitor insider transaction trends closely; the current heavy selling pressure is a significant bearish signal that warrants attention.
  • The stock is trading below its 50-day and 200-day moving averages ($207.33 and $194.21), suggesting a bearish trend. A reclaim of these levels would be a key bullish signal.
  • Given the high debt-to-equity ratio, investors should assess the company's interest coverage and its ability to manage debt obligations in the current economic climate.
Key Catalysts
Bearish Heavy Insider Selling Pressure

Insiders have sold $98.7 million worth of stock against minimal purchases, indicating a lack of confidence from management and potentially signaling future price weakness.

Source: Insider Transactions
Bearish Break Below Key Moving Averages

The stock is trading below its 50-day and 200-day moving averages ($207.33 and $194.21), suggesting a bearish technical trend that could lead to further price declines.

Source: Technical Analysis
Bullish Consistent EPS Beats

Morgan Stanley has consistently beaten analyst EPS estimates in recent quarters, demonstrating operational efficiency and the potential for earnings upside.

Source: Earnings Reports
Bullish Positive Analyst Price Targets

The median analyst price target of $226.50 implies a 19.2% upside from the current price, suggesting Wall Street sees value despite current headwinds.

Source: Wall Street Analysts
Market Outlook
Morgan Stanley's outlook is cautiously balanced, with a median analyst price target of $226.50 suggesting a potential 19.2% upside from the current $190.02 price. The company is expected to continue its strong revenue growth trajectory, with current year projections at 17.00% year-over-year. The firm's strong profit margins and consistent earnings beats provide a fundamental underpinning for potential recovery. However, the significant insider selling and bearish technical indicators present substantial headwinds. A failure to reclaim key moving averages could lead to further downside, testing the $184 low price target. Positive catalysts would likely need to include a clear shift in insider sentiment or a strong market-wide rally in financial services to overcome current selling pressure.

Key Statistics

Market Cap 298.44B
P/E Ratio 15.35
EPS (TTM) 12.38
Dividend Yield 2.18%
52 Week High 232.25
52 Week Low 151.84
Morgan Stanley's valuation appears reasonable relative to its sector, with a P/E ratio of 15.35 compared to the sector average of 16.5, and a price-to-sales ratio of 3.83 which is in line with the sector median. The company demonstrates strong profitability with a net profit margin of 25.90% and a return on equity of 17.97%, both significantly outperforming sector averages (13.8% ROE). However, its debt-to-equity ratio of 5.17 is considerably higher than the sector average, indicating a more leveraged balance sheet. Despite strong profit margins and revenue growth of 28%, the current stock price is trading below its fair value and analyst targets, suggesting that the market may be discounting future growth or factoring in the elevated debt levels and insider selling. The company's ability to maintain its current profit margins and manage its debt will be critical for future performance.

Earnings & Growth Analysis

Morgan Stanley's recent earnings reports show a pattern of beating analyst EPS estimates, with the quarter to June 2026 reporting an EPS of $3.46 against an estimate of $2.93, an 18.09% surprise. However, this beat was accompanied by a price drop of 4.45%. The company has consistently beaten EPS estimates over the last four reported quarters, though the magnitude of the price reaction has been negative in the last two instances. Revenue growth for the current year is projected at a strong 17.00% year-over-year, reaching $82.3 billion.

Key Risks

The primary risk for Morgan Stanley is the significant insider selling, with $98.7 million in sales against minimal purchases, signaling a potential lack of confidence from management. Additionally, the stock is trading below its key 50-day and 200-day moving averages, indicating bearish technical momentum and potential for further price declines. The company's high debt-to-equity ratio of 5.17 also presents a financial risk, especially in a rising interest rate environment.

Technical Indicators i

RSI (14) 20.75
MACD -5.79
SMA 50 207.33
SMA 200 194.21
Technical Rating Bearish
RSI
Oversold
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($207.33) above the 200-day SMA ($194.21), price is trading below the 50-day SMA, RSI at 20.8 suggests oversold conditions; potential bounce setup.

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.74
Strong correlation
Nasdaq 100 (QQQ) +0.67
Moderate correlation
Bitcoin (BTC) +0.25
Weak correlation
Gold (XAU) +0.16
Weak correlation
Check Custom Correlation

How does any other asset move with MS? One year of daily closes, Pearson correlation.

Try

MS Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Entry Strategies pick an entry style

Conservative
$188.12
Slight discount to current
Wait for small dip
Aggressive
$190.02
At current price
Enter now if confident

Risk Management

STOP LOSS
$181.91
MAX LOSS
-3.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (20.8) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$193.76
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$197.53
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$203.17
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Disclaimer
This AI-generated trade plan for MS is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on October 10, 2026.

Growth of $10,000

A $10,000 investment in MS in October 2016 would be worth about $58,360 today, compared with about $36,018 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MS today could grow to about $32,723 by 2036 in the base case, with a bull case near $116,364 and a bear case around $9,202. Projections are statistical simulations, not guarantees.

MS Stock Price Prediction: 2030

CleaRank's simulation projects a price near $305 for MS by 2030 in the base case, from $190 today (1.6x over 4 years). The downside path ends near $137. These are outcomes of a Monte Carlo simulation run on MS's historical return distribution, not price targets, and they assume no dividends are reinvested.

MS simulated price paths by year
Year Downside (10th pct) Base case Upside (90th pct)
2027 $143 $214 $320
2028 $137 $241 $425
2029 $135 $271 $543
2030 $137 $305 $681
2031 $140 $344 $843
2032 $145 $387 $1,034
2033 $151 $436 $1,259
2034 $158 $491 $1,526
2035 $166 $552 $1,840
2036 $175 $622 $2,211

Method: 10,000 simulated price paths using MS's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.

People Also Watch

MS Insider Trading Analysis

Source: SEC Form 4
▲ Bought
$5.6K
1 Transactions
▼ Sold
$98.7M
25 Transactions
● Insiders
22
Active Traders
$ Avg Transaction
$3.8M
Large trades
Recent insider transactions in MS
Date Insider Type Shares Value
Sep 20, 2019
MITSUBISHI UFJ FINANCIAL GROUP, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell 7.9M $326.9M
Mar 22, 2019
MITSUBISHI UFJ FINANCIAL GROUP, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell 6.2M $262.7M
Dec 20, 2019
MITSUBISHI UFJ FINANCIAL GROUP, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell 4.7M $230.6M
Jul 29, 2019
MITSUBISHI UFJ FINANCIAL GROUP, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell 1.6M $70.1M
Oct 29, 2019
MITSUBISHI UFJ FINANCIAL GROUP, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell 1.1M $51.7M
Jan 29, 2019
MITSUBISHI UFJ FINANCIAL GROUP, INC.
Beneficial Owner of more than 10% of a Class of Security
Sell 1.2M $49.6M
Jan 18, 2023
GORMAN JAMES P
Chief Executive Officer
Sell 250.0K $24.2M
Jul 17, 2024
GORMAN JAMES P
Officer and Director
Sell 200.0K $21.0M
Oct 31, 2025
PICK EDWARD N.
Chief Executive Officer
Sell 100.0K $16.4M
Jan 18, 2023
PICK EDWARD N.
Officer
Sell 135.0K $13.1M

Frequently Asked Questions

Is Morgan Stanley stock a buy right now?
Morgan Stanley (MS) is currently rated as 'Hold' by Wall Street analysts, with a consensus score of 59. While the stock exhibits strong revenue growth and profit margins, it is trading below its key moving averages and faces significant insider selling pressure, suggesting caution is warranted.
What is Morgan Stanley's stock price forecast for 2030?
Based on Monte Carlo simulations, Morgan Stanley's projected price range for 2030 is between $136.86 and $681.09, with a base case of $305.31. These are statistical outcomes, not definitive price targets.
What are the key risks facing Morgan Stanley?
The main risks include heavy insider selling totaling $98.7 million, a bearish technical setup with the stock below its 50-day and 200-day moving averages ($207.33 and $194.21), and a high debt-to-equity ratio of 5.17, which is above the sector average.
How does Morgan Stanley compare to its sector peers?
Morgan Stanley shows stronger revenue growth (28% vs. 11.7% sector average) and profit margins (25.90% vs. 13.8% sector average). However, its debt-to-equity ratio (5.17) is higher than the sector median.
What is the Wall Street consensus on Morgan Stanley stock?
The Wall Street consensus for Morgan Stanley is 'Hold', with 26 analysts covering the stock. The median price target is $226.50, suggesting a potential upside of 19.2% from the current price.
What was Morgan Stanley's most recent earnings performance?
In the quarter to June 2026, Morgan Stanley reported an EPS of $3.46, beating the estimate of $2.93 by 18.09%. Despite this earnings beat, the stock price declined by 4.45%.
Are there any significant insider transactions for Morgan Stanley?
Yes, insiders have been heavy net sellers, with $98.7 million in total sales in recent filings, compared to only $5.6 thousand in purchases. This indicates significant selling pressure from within the company.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The stock analysis, trade plans, and AI-generated signals presented for MS are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. They do not represent actual trades made by CleaRank or its affiliates. Stock prices can be volatile and are subject to market, economic, and company-specific risks. Market data is provided "as-is" and may be delayed by 15 minutes or more. We do not guarantee the accuracy, completeness, or timeliness of any data. You should never invest money you cannot afford to lose. Past performance does not guarantee future results. Consult a qualified financial advisor before making any investment decisions. Analysis generated on October 10, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.